Navigation Links
Cognitive Score Changes Over Time May Hint at Dementia
Date:8/19/2008

Study authors stress new method is a complement to current testing,,,,

TUESDAY, Aug. 19 (HealthDay News) -- Yearly changes in a person's performance on cognitive testing may be associated with dementia, new research suggests.

Using a newly developed model to assess the effect of variations in a person's score from year to year, researchers found that just a one point change in variability on cognitive test scores could indicate as much as a fourfold increase in the risk of developing dementia.

"Above and beyond the prediction made by performance on neuropsychological tests, if you take into account the degree to which the individual varies in their cognitive abilities, there's an independent risk of dementia," said study author Roee Holtzer, an assistant professor of psychology and neurology at the Albert Einstein College of Medicine at Yeshiva University in New York City.

Results of the study are published in the Aug. 20 issue of the Journal of the American Medical Association.

Holtzer was quick to point out that the newly developed variability model was a complement to currently used tests, and is not meant to replace them. Additionally, he said, the findings need to be replicated.

Currently, doctors use cognitive function and memory tests to diagnose dementia or mild cognitive impairment. But, these tests compare one person to the "norm" for their age and education level.

Holtzer and his colleagues theorized that changes within an individual's score over time might be an additional tool for diagnosing dementia.

To that end, they developed a model to assess "within-person" variability on commonly used neuropsychological tests that compensated for sex, education, medical illness, and performance on each individual test. The model was then used to evaluate 897 people older than 70 between October 1993 and December 2007. Baseline testing was done, and then the participants had follow-up exams every 12 to 18 months.

During the follow-up, 61 cases of dementia were identified. Twenty-six of these people had scores in the highest quartile of the within-person variability index.

The researchers found that when they controlled for sex, education and medical illness, each one-point difference in the variability scores increased the risk of dementia by nearly four times. If they also factored in adjustments for scores on individual tests, the risk was still more than doubled for each one point difference in the variability model.

"The investigators found that relatively brief measures of memory and executive function reassessed annually would allow physicians to predict of dementia before the patient scores in the clearly impaired range," said Dr. Gary Kennedy, director of the division of geriatric psychiatry at Montefiore Medical Center in New York City.

"This study brings us one step closer to a simple, safe and reliable test of dementia risk," added Kennedy. And, that's important, he said, because once medications are developed to treat dementia, you have to be able to correctly identify who needs the treatment.

More information

To read more about diagnosing dementia, visit the Family Caregiver Alliance.



SOURCES: Roee Holtzer, Ph.D., assistant professor, psychology and neurology, Albert Einstein College of Medicine, Yeshiva University, New York City; Gary Kennedy, M.D., director, geriatric psychiatry, Montefiore Medical Center, New York City; Aug. 20, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Lack of sleep among new school-goers leads to behavioral, cognitive problems
2. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
3. Cognitive Activities Protect Against Alzheimers -- Social and Physical Activities Not Enough
4. Potential new approach to treat cognitive impairments in schizophrenia
5. Cognitive deficits lead to loss of self among cancer patients
6. Research links diet to cognitive decline and dementia
7. First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
8. New research on aging and cognitive training presented at GSAs Annual Meeting
9. Hypertension Linked to Risk of Mild Cognitive Impairment
10. Rhode Island Hospital to study driving ability of cognitively impaired elders
11. Older surgical patients at greater risk for developing cognitive problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: